The Alfred Hospital Lung Transplant Experience.
The management of patients undergoing lung transplantation has continued to evolve, leading to improvements in 90-day and 1-year survival. The significant advancements in donor management and utilization at our center have led to significant increases in lung transplant activity without any compromise in recipient outcomes. Through the use of a patient-centered multidisciplinary model of care involved in all aspects of recipient management, from assessment and waitlisting to pre-, peri- and post-operative care, our lung transplant outcomes represent 2015 world's best lung transplant practice.
Miranda A
MA
Paraskeva
Glen P
GP
Westall
David
D
Pilcher
David
D
McGiffin
Bronwyn J
BJ
Levvey
Trevor J
TJ
Williams
Gregory I
GI
Snell
D046148:Donor Selection; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016040:Lung Transplantation / Q000009:adverse effects / Q000401:mortality / Q000639:trends; D015397:Program Evaluation; D012307:Risk Factors; D013997:Time Factors; D014019:Tissue Donors / Q000600:supply & distribution; D009927:Tissue and Organ Procurement / Q000458:organization & administration / Q000639:trends; D016896:Treatment Outcome; D014739:Victoria / Q000453:epidemiology; D014850:Waiting Lists
D007166:Immunosuppressive Agents